Clarity Capital Partners LLC Eledon Pharmaceuticals, Inc. Transaction History
Clarity Capital Partners LLC
- $280 Billion
- Q2 2025
A detailed history of Clarity Capital Partners LLC transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Clarity Capital Partners LLC holds 11,500 shares of ELDN stock, worth $30,590. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,500
Previous 11,500
-0.0%
Holding current value
$30,590
Previous $39 Million
20.06%
% of portfolio
0.01%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding ELDN
# of Institutions
89Shares Held
36.8MCall Options Held
48.5KPut Options Held
51.3K-
Bvf Inc San Francisco, CA6.29MShares$16.7 Million0.67% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.57MShares$9.49 Million0.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.32MShares$8.83 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN2.6MShares$6.92 Million1.08% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L31.96MShares$5.21 Million1.46% of portfolio
About Eledon Pharmaceuticals, Inc.
- Ticker ELDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,756,800
- Market Cap $36.6M
- Description
- Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...